A detailed history of Sb Investment Advisers (Uk) LTD transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 27,904,963 shares of RLAY stock, worth $165 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares
27,904,963
Previous 27,904,963 -0.0%
Holding current value
$165 Million
Previous $232 Million 21.45%
% of portfolio
1.68%
Previous 2.29%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

BUY
$32.81 - $45.1 $916 Million - $1.26 Billion
27,904,963 New
27,904,963 $1.19 Billion

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $709M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Sb Investment Advisers (Uk) LTD Portfolio

Follow Sb Investment Advisers (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sb Investment Advisers (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sb Investment Advisers (Uk) LTD with notifications on news.